Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hock

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Diseases of the Colon and Rectum|November 1, 1993
ColpocystodefecographyD Hock, R Lombard, C Jehaes, et al.
Archives of Histology and Cytology|January 1, 1989
The heart is the center of a new endocrine, paracrine, and neuroendocrine systemW G Forssmann, K Nokihara, M Gagelmann, et al.
Therapeutic Drug Monitoring|November 16, 2018
Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab- and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution AssayBarry D Hock, Judith L McKenzie, Liping Goddard, et al.
Journal of Immunological Methods|September 17, 2019
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serumBarry D Hock, Stewart M Smith, Christopher J McEntyre, et al.
Leukemia Research|February 7, 2009
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemiaB D Hock, L J Fernyhough, S M Gough, et al.
Leukemia Research|December 23, 2003
The soluble form of CD83 is present at elevated levels in a number of hematological malignanciesBarry D Hock, Lisa F Haring, Alexander Steinkasserer, et al.
Internal Medicine Journal|November 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centreBarry D Hock, Katie S Mulholland, Peter Ganly, et al.
Internal Medicine Journal|September 25, 2016
Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patientsB D Hock, N D McIntosh, J L McKenzie, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|February 2, 2002
[Value of MRCP for detection of choledocholithiasis in symptomatic patients: one-year experience with a standardized high resolution breath-hold technique]D Brisbois, O Plomteux, A Nchimi, et al.
Plos One|September 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumabBarry D Hock, Liping Goddard, Sean A MacPherson, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Diseases of the Colon and Rectum|November 1, 1993
ColpocystodefecographyD Hock, R Lombard, C Jehaes, et al.
Archives of Histology and Cytology|January 1, 1989
The heart is the center of a new endocrine, paracrine, and neuroendocrine systemW G Forssmann, K Nokihara, M Gagelmann, et al.
Therapeutic Drug Monitoring|November 16, 2018
Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab- and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution AssayBarry D Hock, Judith L McKenzie, Liping Goddard, et al.
Journal of Immunological Methods|September 17, 2019
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serumBarry D Hock, Stewart M Smith, Christopher J McEntyre, et al.
Leukemia Research|February 7, 2009
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemiaB D Hock, L J Fernyhough, S M Gough, et al.
Leukemia Research|December 23, 2003
The soluble form of CD83 is present at elevated levels in a number of hematological malignanciesBarry D Hock, Lisa F Haring, Alexander Steinkasserer, et al.
Internal Medicine Journal|November 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centreBarry D Hock, Katie S Mulholland, Peter Ganly, et al.
Internal Medicine Journal|September 25, 2016
Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patientsB D Hock, N D McIntosh, J L McKenzie, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|February 2, 2002
[Value of MRCP for detection of choledocholithiasis in symptomatic patients: one-year experience with a standardized high resolution breath-hold technique]D Brisbois, O Plomteux, A Nchimi, et al.
Plos One|September 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumabBarry D Hock, Liping Goddard, Sean A MacPherson, et al.
Pageof 10